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Liver regeneration from the facultative hepatic stem
cells, the oval cells, takes place in situations in which
liver regeneration from pre-existing hepatocytes is
prevented. Different models have been used to stim-
ulate oval cell response. Many of them involve the use
of carcinogenic agents with or without partial hepa-
tectomy. In this study we show that adenovirus-medi-
ated gene transfer of the suicide gene thymidine ki-
nase followed by ganciclovir administration caused
hepatotoxicity of variable intensity. Rats with moder-
ate elevation in serum transaminases recovered nor-
mal liver architecture few weeks after adenovirus in-
jection. In contrast, rats with severe liver damage
exhibited a marked and persisting activation of oval
cells accompanied by ductular hyperplasia. In some
rats, such lesion eventually evolved to cholangiofi-
brosis and in one rat to cholangiocarcinoma. Deposi-
tion of fibronectin and increased number of hepatic
stellate cells were found in association with oval cells
and cholangiofibrotic lesions. Hepatocyte growth fac-
tor was hyperexpressed in the livers with intense oval
cell response or ductular proliferation, suggesting a
participation of this factor in those lesions. In sum-
mary, our data demonstrate activation of oval cell
response after gene transfer of thymidine kinase fol-
lowed by ganciclovir administration. These findings
indicate that high doses of this therapy causes liver
damage together with an impairment in hepatocellu-
lar regeneration. (Am J Pathol 2000, 157:549–559)
It has been postulated that there is a liver-committed
stem cell compartment that does not take part in normal
tissue renewal but does proliferate in response to certain
forms of liver injury.1,2 Oval cells are considered to be the
progeny of activated hepatic stem cells, a belief sup-
ported by the fact that this particular cell type expresses
markers thought to be characteristic of stem cells.3 The
principle supported by studies in animal models of liver
injury is that oval cells participate in the restoration of the
functional liver mass after hepatic damage when the
noxious agent reduces the number of viable liver cells but
the ability of the surviving hepatocytes to regenerate is
either totally nullified or at least severely impaired. Exper-
imental models to activate the oval cell compartment
include the performance of 2/3 hepatectomy on rats
treated with acetyl-aminofluorene (AAF),4 the administra-
tion of dipin to mice,5 and of furan to rats.6 Oval cell
proliferation has also been shown in rats treated with
galactosamine and in Long-Evans Cinnamon rats which
have a defect in the ATP7B gene resulting in toxic accu-
mulation of copper in the liver.7,8 Proliferation of oval cells
also takes place in p21CIP1/WAF1 transgenic mice when
overexpression of the transgene is directed to the liver.9
Stem cells are considered to be a possible target for
carcinogenic agents, since their longevity permits the
development of the multistep process leading to tumor
formation along the prolonged latency period between
exposure and progression to cancer.10 However, the role
of oval cells in the pathogenesis of primary tumors in the
liver is still unresolved.
During past years, the approach based on the transfer
of so-called suicide genes to tumor cells has emerged as
a promising strategy in cancer gene therapy.11 A com-
monly used suicide gene is herpes simplex virus (HSV)
thymidine kinase (tk) which confers sensitivity to ganci-
clovir (GCV). HSV-tk transforms GCV into a phosphory-
lated derivative with potent cytotoxic activity. In a previ-
ous study we reported that intraportal injection of an
adenoviral vector expressing HSV-tk (AdCMVtk) followed
by GCV administration resulted in marked reduction of
the tumor mass in an animal model of multifocal hepato-
cellular carcinoma, but this antitumoral effect was ac-
companied by high mortality due to severe hepatotoxic-
ity.12 Although early toxic liver changes have been
described after gene therapy with AdCMVtk plus GCV,13
the long term follow up of animals subjected to this treat-
ment has not been previously reported. The present
study was undertaken to characterize the evolution of the
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liver damage which occurs in rats after intravascular
injection of AdCMVtk followed by GCV administration.
Our results show that this treatment causes hepatotoxic-
ity and stimulates oval cell proliferation. In animals with
moderate hepatocellular damage activation of oval cells
was inconspicuous and liver architecture was normal few
weeks after injection of the adenovirus. However, in
cases with more intense liver cell damage a marked
proliferation of oval cells was found during the first 6
weeks. This reaction was followed by nodular regenera-
tion and marked ductular proliferation. Some animals
developed intestinal metaplasia and cholangiofibrosis.
Cholangiocarcinoma was found in one rat sacrificed at
week 36. Our data show that the AdCMVtk/GCV system is
a useful model to activate the oval cell compartment, to
explore the pathophysiology of the liver stem cells and to
study the pathological changes which result from distur-
bances in oval cell differentiation. Furthermore, our data
emphasize the need to adjust the dose of the adenoviral
vector when considering treatment of liver neoplasms
using suicide genes to avoid undue toxicity.
Materials and Methods
Male Wistar rats (250 to 290 g) were obtained from Harlan
Interfauna Iberica, S.A. (Barcelona, Spain). OV-6, BD1,
BD2 monoclonal antibodies were gifts from Dr. Douglas
Hixson (Brown University, Providence, RI). Proliferating
cell nuclear antigen (PCNA) and -smooth muscle actin
antibodies were from Dako A/S (Copenhagen, Denmark).
Monoclonal antibody against desmin was from Sigma
Chemical Company (St. Louis, MO). Anti-fibronectin was
provided by Dr Angeles Garcia (CSIC, Madrid, Spain).
Polyclonal antibodies against TGF-, HGF, and c-met
were purchased from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA). HGF cDNA was a gift from Dr. Jiro
Fujimoto (University of Hyogo, Nishinomiya, Japan). Anti-
mouse immunoglobulin labeled with peroxidase or with
fluorescein isothiocyanate (FITC) and anti-rabbit immu-
noglobulin labeled with FITC and 3,3-diaminobenzidine
tetrahydrochloride were from Sigma. Ganciclovir
(Cymevene) was purchased from Roche S.A. (Madrid,
Spain) and incorporated into time-released ALZET os-
motic pumps supplied by Criffa S.A. (Barcelona, Spain).
Adenoviral Vectors
The recombinant adenoviral vectors AdCMVtk and
AdCMVlacZ expressing the HSV-tk gene and the reporter
gene lacZ under the control of the cytomegalovirus en-
hancer/promoter (CMV) were constructed as previously
described.11 These vectors were expanded in 293 cells
and purified by double cesium chloride ultracentrifuga-
tion. The purified virus was extensively dialyzed against
10 mmol/L Tris per 1 mmol/L of MgCl2 and stored in
aliquots at 80°C. The virus titer was determined by
spectrophotometry and plaque assay as described.11
Treatment Protocol
Young adult male Wistar rats weighing 250 to 290 g were
in cages maintained at room temperature under a 12-
hour light/dark illumination cycle in an approved biohaz-
ard animal room. Standard pelleted chow and drinking
water were administered ad libitum throughout the entire
experimental protocol. All of the animal experimentation
described in this study was conducted according to in-
stitutionally approved protocol.
The rats were divided into two groups: 53 in the exper-
imental group and 27 in the control group. Each rat in the
experimental group received 2 ml of suspension contain-
ing 4  1010 pfu/kg of AdCMVtk which was slowly in-
jected into the tail vein. At this moment an osmotic pump
(2ML2 ALZET) with GCV solution was placed intraperito-
neally to deliver the drug at the dose of 30 mg/kg/day for
14 days. Control rats received 2 ml of phosphate-buff-
ered saline (PBS) into the vein tail and PBS was also
placed into the pump. After 14 days the pumps were
removed and checked for complete emptying.
Rats from the experimental and control group were
sacrificed under ether anesthesia at 1, 2, 3, 4, 5, 6, 7, 8,
and 36 weeks after the administration of the adenoviral
vector or PBS (Table 1). To test the adenovirus-mediated
gene transfer efficiency to liver cells, a group of 6 rats
were given an intravenous injection of AdCMVlacZ at the
same those as AdCMVtk. After 48 hours, livers were
removed and 5-bromo-4-chloro-3-indolyl--D-galacto-
side staining (X-gal) was used to detect lacZ gene ex-
pression as previously described.11
Histology, Histochemistry,
Immunohistochemistry, and Biochemistry
Liver tissue was removed at each time point as indicated
above and was divided and fixed in either 10% buffered
neutral formalin or placed in OCT compound, frozen in
cold 2-metylbutane (Merck, Darmstadt, Germany) and
stored at 80°C. All of the staining procedures for light
microscopy were performed on 4-m-thick, paraffin-em-
bedded sections or on 6-m-thick, frozen sections. Rou-
tine histological examinations were made for all liver tis-
sue samples on sections (paraffin and frozen) stained
with hematoxylin-eosin. Histochemical demonstration of
glucose-6-phosphatase (G6Pase) activity was performed
according to the method of Wachstein and Meisel.14
Immunohistochemical staining was carried out in fro-
zen tissue with monoclonal antibodies against OV6, BD1,
BD2, and desmin using as a second antibody anti-mouse
immunoglobulin labeled with peroxidase. The chromo-
genic reaction was developed with diaminobenzidine.
Fibronectin immunoreactivity was detected with anti-rab-
bit immunoglobulin labeled with FITC. Detection of
PCNA, -smooth muscle, HGF, c-met and TFG- was
performed after heating formalin-fixed paraffin-embed-
ded tissue sections by 800-W microwaving in 0.01
mol/L citric acid buffer pH 6.0, followed by incubation
with the corresponding antibody and anti-mouse (PCNA
and -smooth muscle actin) or anti-rabbit (HGF, c-met,
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and TFG-) immunoglobulin labeled with peroxidase. For
each antibody, negative controls were performed by
omitting the primary antibody from the protocol. Negative
control sections were included with c-met (SP260) anti-
body that had been neutralized by pretreatment with the
immunizing peptide sc-162P (Santa Cruz).
Aspartate aminotransferase (AST) levels were deter-
mined in serum by automatic calorimetric assays (Tech-
nicon RA-1000, Bayer).
Western Blot Analysis of c-met Protein
Expression
Frozen liver tissue was homogenized in RIPA buffer (9.1
mmol/L Na2HPO4, 1.7 mmol/L NaH2PO4, 150 mmol/L
NaCl, 1.0% Nonidet P-40, and 0.1% sodium dodecyl
sulfate (SDS), 0.05% sodium deoxycholate, and 1.1
mmol/L phenylmethylsulfonyl fluoride) with protease in-
hibitor cocktail tablets (Boehringer Mannheim, Mann-
heim, Germany). The protein content was determined by
the Bradford assay (Bio-Rad, Mu¨nchen, Germany). A
total of 30 g of protein was dissolved in the sample
buffer heated at 90°C for 5 minutes and analyzed by
7.5% SDS-polyacrylamide gel electrophoresis. Immuno-
reactivity was visualized by incubation with Supersignal
CL-HRP chemiluminescence substrate (Pierce Chemical,
Rockford, IL).
Northern Blot
Total RNAs were isolated by a modified acid/guanidine
thiocyanate/phenol/chloroform method15 using ULTRA-
SPEC (Biotecx Laboratories, Inc, Houston, TX) reagents
according to the manufacturer’s instructions. RNA con-
centrations were determined spectrophotometrically.
For Northern blotting total RNA (20 g) was electro-
phoresed under denaturing conditions, transferred onto
nylon membranes positively charged (Boehringer Mann-
heim), and fixed by UV cross-linking. The quality and
comparative quantity was estimated on gels by ethidium
bromide staining. The 2.6 kb rat HGF cDNA and the
cDNA probe for -actin was labeled by random priming
(Amersham Pharmacia Biotech Inc. Buckinghamshire,
UK) and used for Northern blot. Membranes were prehy-
bridized for 1 hour and hybridized 2 hours with QuikHyb
(Stratagene, La Jolla, CA) at 68°C. The membranes were
stringently washed and exposed to Kodak XAR film.
In Situ Hybridization
The rat albumin cDNA used for in situ hybridization (ISH)
corresponds to 700 bp fragment from the 3 end of the rat
albumin gene cloned into pGEM1. After linearizing the
vector with HindIII or EcoRI, a digoxygenin-labeled anti-
sense and sense cRNA probe were synthesized with T7
or SP6 RNA polymerase (BRL, Gibco) respectively using
the DIG RNA labeling kit (Boehringer Mannheim) accord-
ing to manufacturer’s instructions. The cRNA probes
were purified by ethanol precipitation and correct size
verified by 1.5% agarose gel electrophoresis. Typical
yields of 10 g of DIG-labeled cRNA for 1 g of DNA
were obtained.
ISH was performed on paraffin-embedded tissue sec-
tions. After deparaffinization and rehydration, sections
were immersed in 0.2% Triton/PBS pH 7, followed by
incubation with proteinase K (80 g/ml) for 30 minutes at
37°C. They were then acetylated in triethanolamine con-
taining 0.25% acetic anhydride. The sections were hy-
bridized in buffer containing 0.01 mol/L Tris/HCl, pH 7.5,
12.5% Denhardt’s solution (0.02% Ficoll, 0.02% bovine
serum albumin, 0.02% polyvinylpyrrolidone), 2X SSC,
50% formamide, 0.5% SDS, 250 g/ml salmon sperm
DNA, 5 mg/ml sodium pyrophosphate, and the cRNA
probe for 18 hours at 45°C. The following day, the sec-
tions were washed twice in 2X SSC/0.1% SDS for 10
minutes at room temperature, twice in 0.1X SSC/0.1%
SDS at 43°C, and then treated with RNase A at 37°C for
15 minutes. Immunological detection of albumin mRNA
was performed by reaction with anti-DIG antibody cou-
pled to alkaline phosphatase using nitroblue tetrazolium
and 5-bromo-4-chloro-3-indolphosphate in a dark box for







1 6 Infiltration of mononuclear
cells at the periportal
areas
2 6 Ductular proliferation of
different intensity at the
portal tracts
3 4 Infiltration of the hepatic
lobule by oval cells
irradiating from the
portal tracts
1 Few oval cells in some
portal tracts
1 Normal liver architecture
4 2 Massive infiltration and
proliferation of oval cells
2 Few oval cells in a few
portal tracts
2 Normal liver architecture




2 Few oval cells in a few
portal tracts
6 Normal liver architecture




7 4 Normal liver architecture
1 Proliferating bile ducts with
intestinal metaplasia
8 3 Ductular proliferation with
intense fibrosis and
intestinal metaplasia
2 Normal liver architecture
36 1 Cholangiocarcinoma
2 Normal liver architecture
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2 hours, after which the color reaction was stopped with
TE buffer and the slides were mounted in glycerol/PBS.
Negative controls included hybridization with the sense
probe and omission of the RNA probe or anti-DIG anti-
body.
Statistical Analysis
Mann-Whitney U tests were used to compare variables




After intravenous injection of AdCMVlacZ, about 75% of
hepatocytes stained positively with X-gal. There was,
however, a total absence of transduction of bile duct
epithelial cells (data not shown). No staining was found in
organs other than the liver except a faint signal in renal
proximal tubules in one of the rats tested.
Rats which received AdCMVtk followed by GCV treat-
ment suffered a chain of morphological changes in the
liver which are summarized in Table 1. As shown in this
table, groups of 6 animals were sacrificed at weeks 1, 2,
3, 4, 7, and 8. Fourteen rats were sacrificed at weeks 5
and 6 and three at week 36. A moderate infiltration of
mononuclear cells in the portal tract was observed on the
first week after administration of the adenovirus. On the
second week, in four of the six rats studied there were
abundant acidophilic bodies and apoptotic bodies (Fig-
ure 1A) indicating severe hepatocellular damage. In
these rats a ductular proliferation was apparent in the
vicinity of the limiting plate where small oval cells forming
duct-like structures were identified (Figure 1B). These
Figure 1. Liver sections obtained from rats at weeks 2 and 4 after administration of AdCMVtk plus ganciclovir. A: After 2 weeks, periportal region shows marked
proliferation of ductular formations and small oval cells (arrows) with ovoid nucleus and peripheral heterochromatin penetrating into the hepatic lobule (H&E,
400). B: Histopathological changes in the liver showing cellular damage with the presence of acidophilic bodies (arrows), apoptotic bodies (arrowheads) and
swelling of hepatocytes resulting in paleness and foamy appearance of the cytoplasm (H&E, 200). C: At week 4, the liver showed marked proliferation of oval
cells (arrows) invading densely the hepatic lobule from the portal tracts. These cells penetrate as cords and ductular formations between hepatocytes. Ballooning
degeneration and acidophilic hepatocytes are observed (arrowheads) (200). D: BD2 immunohistochemical staining of liver sections at the fourth week. Intense
staining of proliferating oval cells which fan out from the portal tract (PT) inside the hepatic lobule (100).
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cells reacted positively with OV-6 and BD2, two mono-
clonal antibodies directed against rat oval cell markers.16
On the third week after administration of AdCMVtk,
signs of liver cell damage and a conspicuous dysplasia
of hepatocytes together with the presence of oval cells in
the portal tracts which tended to infiltrate the hepatic
lobules was observed in 4 animals. In two other animals
both hepatocellular damage and oval cell reaction were
less noticeable. On the fourth week, two rats exhibited
signs of severe liver cell injury with swelling and balloon-
ing degeneration of hepatocytes accompanied by a mas-
sive proliferation of oval cells which invaded the hepatic
lobule radiating from the portal spaces along the plates of
hepatocytes (Figure 1, C and D). These small epithelial
cells which stained positively for BD2 and OV-6, were
disposed as rows or clusters and frequently formed
ductular structures (Figure 1, C and D). Proliferating oval
cells showed positive PCNA staining. Two rats of this
group showed less liver damage with few oval cells at the
portal tracts. A normal liver architecture was observed in
two more rats (Table 1).
On weeks 5 and 6, six rats showed massive substitu-
tion of the liver tissue by proliferating small OV-6 and BD2
positive cells (Figure 2A) which diffusely infiltrated the
cords of damaged and dysplastic hepatocytes. In two
rats, oval cell proliferation was much less intense and in
six animals liver architecture was normal. As shown in
Figure 2B, in animals with marked activation of the stem
cell compartment it was possible to observe nodules of
basophilic hepatocytes which showed a round nuclei and
scant cytoplasm and were frequently surrounded by
small OV-6 and BD2 positive cells (Figure 2C) which
stained positively for PCNA. Whereas oval cells lacked
G6Pase activity, this enzymatic activity was present in the
nodules of small hepatocytes (Figure 2D) although at
levels considerably lower than those observed in hepa-
tocytes of a normal liver (data not shown). We also ana-
lyzed by in situ hybridization the expression of albumin
mRNA as an additional marker of hepatocellular differen-
tiation. We observed that the levels of albumin transcripts
were low in the old damaged hepatocytes while both oval
cells and the nodules of small basophilic hepatocytes
showed strong albumin mRNA expression (Figure 2E).
Thus, the presence in these nodules of an intense albu-
min signal (as in oval cells) and a G6Pase activity which
is intermediate between OV-6 positive cells (absent
G6Pase) and mature normal hepatocytes (high G6Pase
activity) strongly suggests that the small basophilic hepa-
tocytes represent newly formed liver cells which derive
from oval cells and replace old damaged hepatocytes at
the portal areas.
Interestingly, animals which developed marked prolif-
eration of oval cell at 3, 4, 5, and 6 weeks after the
administration of adenovirus, showed at the time of sac-
rifice higher serum levels of aspartate-aminotransferase
(869  239.3 UI/ml) than rats with small (135.6  45.9;
P  0.01) or absent oval cell reaction (and 83.00  10.5;
P 0.01 versus cases with intense oval cell proliferation).
On week 7, two rats showed a nodular pattern of
hepatocellular regeneration and persistence of proliferat-
ing ductules with positive oval cell markers at the edge of
the nodules (Figure 2F). The rest of the rats presented
normal liver architecture. Similarly, four of six rats sacri-
ficed at week 8 showed nodular hepatocytic regeneration
with abundant OV-6 and BD2 positive ductular formations
surrounding the nodules (Figure 3A). These hyperplastic
ductules showed positive PCNA staining indicating pro-
liferative activity of the epithelial cells (Figure 3B). At this
time point most of the bile ductular cells of such lesions
also stained positively with BD1, an antibody which rec-
ognizes mature bile duct epithelium.17 In one of these
rats, proliferating bile ducts were supported by a thin
fibrotic stroma and some of the ductules were filled with
mucus and exhibited intestinal metaplasia and goblet
cells. In three rats, ductular proliferation was more in-
tense and periductular fibrosis was more prominent (Fig-
ure 3C). Some of the glandular structures in these cholan-
giofibrotic lesions exhibited also intestinal metaplasia
with the presence of enterocyte differentiation and goblet
cells (Figure 3D). Expression of HGF was detected by
immunohistochemistry only in metaplastic glands (Figure
3E). Immunohistochemical expression of the HGF recep-
tor, c-met, was found in metaplastic glands and dysplas-
tic bile epithelium of proliferating ductules (Figure 3F).
Expression of c-met was less intense in non-dysplastic
proliferating ductules. These data were confirmed by
Western blot that demonstrated a 140-kd band which
was more pronounced in the liver from rats with cholan-
giofibrosis or with ductular proliferation and intestinal
metaplasia than in normal liver (Figure 4). A cholangio-
carcinoma with glands which displayed positivity for both
c-met and PCNA was found in one of the three rats
sacrificed at week 36.
Interestingly, animals which developed nodular trans-
formation and ductular hyperplasia or cholangiofibrosis
at weeks 7 or 8 after the administration of the adenovirus
showed at the time of sacrifice higher serum levels of
aspartate-aminotransferase (342.66  113 UI/ml) than
rats with normal liver architecture (113  19 UI/ml)
(P  0.05).
Role of Hepatic Stellate Cells and Growth
Factors in Proliferation of Oval Cells
In livers showing proliferation of oval cells irradiating from
the portal area into the hepatic lobule, we observed that
the proliferating cells were surrounded by fibronectin
deposition (Figure 5A). Intermingled with this extracellu-
lar matrix component, there were many desmin positive
cells, indicating a participation of HSC in this modality of
liver cell regeneration (Figure 5B). HSC showed positivity
for -smooth muscle actin, especially in cholangiofibrotic
lesions found on the 8th week after AdCMVtk administra-
tion (Figure 5C). In these lesions abundant fibronectin
deposition and TGF- were found surrounding the prolif-
erating bile ducts (Figure 5, D and E).
It has been reported that HGF is expressed by sinu-
soidal lining cells in close vicinity to proliferating oval
cells in other experimental designs.20 This factor appears
to play an important role in all aspects of stem cell be-
havior including proliferation, migration and differentia-
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Figure 2. Liver sections obtained at weeks 6 and 7 after administration of AdCMVtk plus ganciclovir. A: BD2 immunohistochemical staining of proliferating oval
cells 6 weeks after administration of adenovirus. The liver parenchyma has been replaced by ductular structures which are decorated with anti-BD2 (40). B:
Arrows indicate a nodule of small hepatocytes which appear to replace the dysplastic and swollen hepatocytes of the damaged liver at week 6 (H&E, 200).
C: Immunohistochemical staining for BD2 showing positivity of oval cells around the portal tract while the new and small hepatocytes are negative for this marker
(200). D: Histochemical staining of glucose-6-phosphatase in the same liver specimen, showing low activity of the enzyme in the nodule of small hepatocytes
(200). E: In situ hybridization for albumin mRNA showing a strong positivity in the nodule of new hepatocytes and positivity in the oval cells close to the portal
tracts in contrast with the low signal in old damaged hepatocytes. F: Seven weeks after administration of AdCMVtk one rat showed nodular regeneration and
proliferation of oval cells at the edge of the nodules (H&E, 40).
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Figure 3. Light micrographs at 8 weeks after administration of adenoviral vector. A: Section of the liver from one rat showing nodular regeneration with marked
bile ductular hyperplasia exhibiting OV-6 positivity (40). B: PCNA immunostaining of proliferating ductules (200). C: Cholangiofibrosis at week 8 with marked
dysplasia, hyperchromasia and presence of mitosis in dysplasic glands (H&E, 200). D: Intestinal metaplastic glands with enterocyte-like and goblet cells (PAS,
400). E: Intestinal metaplastic glands showing immunoreactivity for HGF (400). F: Immunohistochemical staining of c-met showing strong expression of this
protein in intestinal metaplastic glands and weaker in biliary ductular formations. F: Negative control of c-met immunohistochemistry after incubation of the anti
c-met antibody with the immunizing peptide. G: PCNA immunostaining in the cholangiofibrotic lesion of the same specimen demonstrating intense positivity in
dysplastic ductular structures (400).
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tion.21 Thus, we have analyzed by Northern blot the ex-
pression of HGF in the liver in our model. As shown in
Figure 6, HGF mRNA was not detected in normal liver.
However, we found very high levels of HGF mRNA in the
liver at weeks 1 and 2 after administration of adenovirus
by Northern Blot. The amount of HGF transcripts de-
creased slightly by week 3 but increased on subsequent
weeks although only in animals with persistent oval cell
proliferation. In cholangiofibrosis HGF mRNA expression
was present but at levels which were lower than in cases
with high number of proliferating oval cells.
Discussion
The use of suicide genes has been proposed as an
attractive modality of cancer gene therapy. The most
commonly used suicide gene is HSV-tk which transforms
GCV into a triphosphorylated derivative. This compound
blocks DNA synthesis and although it is especially toxic
for dividing cells, it can also cause damage of non-
dividing epithelial cells such as hepatocytes. Although
liver toxicity of AdCMVtk/GCV has already been de-
scribed,13 long-term follow up of the liver lesion has not
been previously reported. Here we show that administra-
tion of adenovirus containing HSV-tk followed by GCV
treatment causes liver damage of diverse intensity. This
variability could be due to differences in transduction
efficiency or to differences in individual susceptibility to
the treatment. In those rats showing severe hepatocellu-
lar injury and marked elevation of serum transaminases
we observed at weeks 3 and 4 an intense oval cell
reaction which was massive at weeks 5 and 6 when
hepatocytic differentiation of the oval cells could be de-
tected as nodules of newly formed small hepatocytes
near the portal tracts. In contrast, in rats with less intense
liver damage and lower serum transaminases oval cell
response was slight or absent. These findings suggest
that the toxic GCV derivative may cause liver cell damage
in a way that division of mature hepatocytes is prevented
leading to activation of the stem cell compartment.
There is evidence that liver stem cells reside in bile
ducts20 and, since bile duct cells are not transduced
when adenoviral vectors are administered systemically,
the facultative stem cells present in the bile ducts might
be responsible for the oval cell response when damaged
hepatocytes cannot regenerate. However, it is also pos-
sible that stem cells are periductular cells10 which could
also be protected from adenoviral infection.
Our data show that after the 7th week some rats devel-
oped a nodular regenerative pattern with abundant pro-
liferating ducts surrounding the hepatocellular nodules.
This type of lesion would be compatible with a differen-
tiation of oval cells along both hepatocytic and biliary
epithelium lineages. Three rats sacrificed at week 8 de-
veloped cholangiofibrosis and a cholangiocarcinoma
was found in one rat examined at week 36. Cholangiofi-
brotic lesions showed features of intestinal-like differen-
tiation (intestinal metaplasia) as reflected by the pres-
ence of goblet cells and columnar enterocyte-like cells.
Similar findings were described by Sirica et al in rats
treated with furan where they found increased c-met
expression in cholangiofibrotic lesions and in later-devel-
oped cholangiocarcinoma.21–23 In our rats, as in the furan
model,24 the increased expression of c-met in proliferat-
ing ductules and in cholangiofibrosis was also associ-
ated with features of dysplasia and intestinal metaplasia
and with a strong PCNA staining indicating enhanced
proliferative activity. These findings suggest a role of
c-met in malignant transformation. Expression of c-met
was less intense in non-dysplastic proliferating ductules
a finding which is compatible with the morphogenetic role
of this receptor in particular for structures with lumen
formation.25
In the model of hepatic stem cell activation here de-
scribed, as it has also been demonstrated in other mod-
els,26 we show a functional association between HSC
and oval cells. In livers showing proliferation of oval cells
irradiating from the portal area into the hepatic lobule,
desmin positive HSC were observed accompanying the
oval cells invading the hepatic lobule, with an apparent
parallelism between oval cell proliferation and prolifera-
tion of desmin-positive HSC. Similarly HSC strongly ex-
pressing -smooth muscle actin have also been ob-
served surrounding bile ducts in late cholangiofibrotic
lesions. Both reactive ductules and HSC27,28 synthesize
TGF- which stimulates HSC in an autocrine and para-
crine manner to produce extracellular matrix (ECM) com-
ponents. We observed that the presence of HSC was
associated with increased deposition of fibronectin and
with the presence of collagen and TGF- around bile
ducts in cholangiofibrotic lesions.
The extracellular matrix, in addition to form a physical
scaffold for liver cells, is also implicated in important
biological functions including differentiation processes
and growth regulation.29,30 HSC besides their role in the
production of ECM also express high levels of HGF
mRNA.29 Infusion of HGF has been shown to enhance
proliferation not only of oval cells but also of HSC.19 Our
study has shown that HGF mRNA is highly expressed in
rats exhibiting either oval cells response or biliary duct
hyperplasia but not in those animals with normal liver
architecture. In cholangiofibrotic lesions the expression
of HGF was detected but at lower levels than in biliary
duct hyperplasia without fibrosis suggesting, as pro-
posed by Nakayama et al in a different model of cholan-
giofibrosis,31 down-regulation of HGF mRNA by TGF-.
The observed association of HGF mRNA expression with
persistent ductular proliferation suggests a role of HGF in
the pathogenesis of this lesion possibly by inhibiting ap-
Figure 4. Representative Western blot of c-met protein. As a positive control1
an established human biliary adenocarcinoma cell line (SK-Cha1) (kindly
provided by Strazzabosco) was used. As shown in the figure a strong
immunoreactive band at 140 kd and a faint band at 170 kd (possibly an
immature precursor of c-met) was observed in SK-Chal cell line. In cases with
intestinal metaplasia associated with cholangiofibrosis2 or with proliferating
bile ducts3 one band at 140 kd was observed. This band was weaker in
normal rat liver.4
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optosis of epithelial cells.32 Seemingly this effect may
favor the evolution of ductular proliferation to cholangio-
carcinoma as it has been observed in one of our rats 9
months after the administration of the adenoviral vector.
Interestingly HGF was detected by immunohistochemis-
try only in glands with intestinal metaplasia, a lesion
which is thought to be associated with the development
of cholangiocarcinoma in both humans and experimental
animals.22,24,33 These findings are in agreement with pre-
vious reports by Sirica34 and by Lai et al35 which showed
selective HGF immunoreactivity in intestinal metaplastic
glands associated with cholangiofibrosis and in neoplas-
Figure 5. A: Week 4 after administration of adenoviral vector. Prominent
deposition of fibronectin can be seen in the portal tract in a liver exhibiting
oval cell proliferation in the same area (IF, 100). B: Abundant desmin-
positive, HSC, were observed intermingled with oval cells 4 weeks after
administration of AdCMVtk (400). C: At week eight after administration of
AdCMVtk, most HSC were strongly positive for -smooth muscle actin
(400). D: The presence of TGF- was detected around the ductular forma-
tions in cholangiofibrotic lesion at week 8 (400). E: Deposition of fibronec-
tin around ductules in the same specimen (400).
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tic glands of subsequently developed cholangiocarci-
noma in the rat furan model.
In summary, we report that the AdCMVtk/GCV system
constitutes a new model to stimulate liver regeneration
based on a potent oval cell response. This system is
simple, does not require partial hepatectomy or the use of
carcinogens, and it is especially useful to generate
ductular hyperplasia as a source of bile duct epithelium
cells. Our results also illustrate the pathological effects in
the liver of a type of gene therapy which is being consid-
ered as a potential treatment for primary and metastatic
liver tumors.
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